Todatry Soorya, Newsom Robert, Wald James, Fina Manuela
University of Minnesota School of Medicine, Minneapolis, MN, USA.
Critical Care Research Center, Regions Hospital, St. Paul, MN, USA.
Int J Pediatr Otorhinolaryngol. 2024 Dec;187:112170. doi: 10.1016/j.ijporl.2024.112170. Epub 2024 Nov 19.
This study aims to assess the utility of the European Academy of Otology & Neurotology - Japanese Otologic Society (EAONO-JOS) and Potsic staging systems in predicting recidivism in pediatric patients with congenital (CC), primary acquired (PA), and secondary acquired (SA) cholesteatoma.
This is a retrospective study on 31 ears from 30 pediatric patients (≤18 years old) treated from 2015 to 2023 for CC, PA, and SA cholesteatoma. Surgical ears were classified according to EAONO-JOS and Potsic staging system. Surgery included transcanal endoscopic ear surgery (TEES), canal-wall up (CWU) or canal-wall down (CWD) mastoidectomy. Primary outcomes included the rate of residual disease at second-look surgery and the rate of recurrence at clinical observation. In addition, stapes erosion, incus erosion, labyrinthine fistula, and extension of disease in the mastoid at primary surgery were investigated for predictivity for recidivism. Descriptive statistics, Kaplan-Meier estimators (KM), and Fisher's Exact tests were used for statistical analysis.
Based on EAONO-JOS staging, the majority (87 %) of cholesteatoma were stage II (100 % for CC, 86.7 % for PA, and 60 % for SA). The rate of residual disease was 45 % for CC, 60 % for PA, and 40 % for SA cholesteatoma. The rate of recurrent disease among the entire cohort was 6.5 %. Univariate analysis on stapes or incus erosion or mastoid extension did not predict residual disease. Within the CC cohort, outcomes suggest a potential correlation between Potsic stage and the risk of residual disease. Insufficient variability in EAONO-JOS stages precluded statistical analysis of the system's ability to predict residual disease. Among the EAONO-JOS stage II cases, those presenting with all three variables (mastoid extension, incus erosion, and stapes erosion) at primary surgery had lower KM survivability (p = 0.010). The type of surgery was predictive of residual disease: CWU was associated with a lower KM survivability compared to TEES (p = .009). CWD was not predictive, given the insufficient sample size. Among all ears, 58 % were managed with TEES.
In this limited cohort of pediatric CC, PA, and SA cholesteatoma, the majority of cases were managed with TEES. Among EAONO-JOS stage II cases, the simultaneous presence of mastoid extension, incus erosion, and stapes erosion at primary surgery demonstrated statistically significant decreased residual-free survivability; TEES approach at primary surgery also has a statistically significant improved residual-free survivability compared to CWU approach.
本研究旨在评估欧洲耳科学与神经耳科学学会 - 日本耳科学会(EAONO-JOS)分期系统和波西奇分期系统在预测先天性(CC)、原发性后天性(PA)和继发性后天性(SA)胆脂瘤患儿复发方面的效用。
这是一项回顾性研究,纳入了2015年至2023年期间接受治疗的30例(≤18岁)患有CC、PA和SA胆脂瘤患儿的31只耳朵。手术耳根据EAONO-JOS和波西奇分期系统进行分类。手术包括经耳道内镜耳手术(TEES)、上鼓室开放(CWU)或下鼓室开放(CWD)乳突切除术。主要结局包括二次探查手术时的残留疾病率和临床观察时的复发率。此外,还研究了初次手术时镫骨侵蚀、砧骨侵蚀、迷路瘘管以及乳突内疾病扩展情况对复发的预测性。采用描述性统计、Kaplan-Meier估计量(KM)和Fisher精确检验进行统计分析。
根据EAONO-JOS分期,大多数(87%)胆脂瘤为II期(CC为100%,PA为86.7%,SA为60%)。CC胆脂瘤的残留疾病率为45%,PA为60%,SA为40%。整个队列中的复发疾病率为6.5%。对镫骨或砧骨侵蚀或乳突扩展进行单因素分析未预测到残留疾病。在CC队列中,结果表明波西奇分期与残留疾病风险之间可能存在相关性。EAONO-JOS分期的变异性不足,无法对该系统预测残留疾病的能力进行统计分析。在EAONO-JOS II期病例中,初次手术时出现所有三个变量(乳突扩展、砧骨侵蚀和镫骨侵蚀)的病例,其KM生存率较低(p = 0.010)。手术类型可预测残留疾病:与TEES相比(p = 0.009),CWU的KM生存率较低。由于样本量不足,CWD无预测性。在所有耳朵中,58%采用TEES治疗。
在这个有限的小儿CC、PA和SA胆脂瘤队列中,大多数病例采用TEES治疗。在EAONO-JOS II期病例中,初次手术时同时出现乳突扩展、砧骨侵蚀和镫骨侵蚀,显示无残留生存率在统计学上显著降低;与CWU方法相比,初次手术采用TEES方法在统计学上也有显著提高的无残留生存率。